Unique ID issued by UMIN | UMIN000010588 |
---|---|
Receipt number | R000012370 |
Scientific Title | Retrospective study on drug interaction of tuberculosis and pulmonary Mycobacterium avium complex disease therapeutic drugs by using data of clinical symptoms and laboratory test results. |
Date of disclosure of the study information | 2013/04/24 |
Last modified on | 2016/04/29 15:24:45 |
Retrospective study on drug interaction of tuberculosis and pulmonary Mycobacterium avium complex disease therapeutic drugs by using data of clinical symptoms and laboratory test results.
Retrospective study on drug interaction of tuberculosis and pulmonary Mycobacterium avium complex disease therapeutic drugs by using data of clinical symptoms and laboratory test results.
Retrospective study on drug interaction of tuberculosis and pulmonary Mycobacterium avium complex disease therapeutic drugs by using data of clinical symptoms and laboratory test results.
Retrospective study on drug interaction of tuberculosis and pulmonary Mycobacterium avium complex disease therapeutic drugs by using data of clinical symptoms and laboratory test results.
Japan |
Tuberculosis and pulmonary Mycobacterium avium complex disease
Pneumology |
Others
NO
1) To retrospectively investigate influence that enzyme induction of rifampicin gives to the effect of each diabetes therapeutic drug.
2) To retrospectively investigate influence that interaction of rifampicin and clarithromycin gives to the effect and side effect frequency of pulmonary Mycobacterium avium complex disease therapeutic drugs.
3) To retrospectively investigate influence that interaction of clarithromycin and levofloxacin gives to the effect of pulmonary Mycobacterium avium complex disease therapeutic drugs.
Safety,Efficacy
Not applicable
1) Study on interaction with rifampicin and diabetes therapeutic drugs in tuberculosis patients: blood glucose and hemoglobin A1c level.
2) Study on interaction with rifampicin and clarithromycin in pulmonary Mycobacterium avium complex disease patients: clinical symptoms of subjects (cough, sputum and hemosputum etc. ), chest radiographic findings, examination of sputum (smear and culture) and clinical laboratory test results.
3) Study on interaction with clarithromycin and levofloxacin in pulmonary Mycobacterium avium complex disease patients: clinical outcome of subjects (smear and culture test).
Observational
Not applicable |
Not applicable |
Male and Female
1) Study on interaction with rifampicin and diabetes therapeutic drugs in tuberculosis patients: tuberculosis patients with diabetes who administered rifampicin from 2008 to 2012.
2) Study on interaction with rifampicin and clarithromycin in pulmonary Mycobacterium avium complex disease patients: pulmonary Mycobacterium avium complex disease patients who received drug therapy from 2008 to 2012.
3) Study on interaction with clarithromycin and levofloxacin in pulmonary Mycobacterium avium complex disease patients: pulmonary Mycobacterium avium complex disease patients who received drug therapy from 2010 to 2012.
None.
50
1st name | |
Middle name | |
Last name | Takao Aoyama |
Tokyo University of Science
Faculty of Pharmaceutical Sciences
2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan
04-7124-1501
t-aoyama@rs.noda.tus.ac.jp
1st name | |
Middle name | |
Last name | Takao Aoyama |
Tokyo University of Science
Faculty of Pharmaceutical Sciences
2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan
04-7124-1501
t-aoyama@rs.noda.tus.ac.jp
Laboratory of pharmacotherapeutics, Tokyo University of Science
None
Self funding
Chemotherapy research institute, Kaken hospital
NO
2013 | Year | 04 | Month | 24 | Day |
Published
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728750/
Our study suggests that the combination of CAM and LVFX causes unfavorable clinical outcomes for pulmonary MAC disease treatment.
Completed
2013 | Year | 04 | Month | 24 | Day |
2013 | Year | 04 | Month | 24 | Day |
2016 | Year | 03 | Month | 31 | Day |
1) Study on interaction with rifampicin and diabetes therapeutic drugs in tuberculosis patients: blood glucose and hemoglobin A1c level.
2) Study on interaction with rifampicin and clarithromycin in pulmonary Mycobacterium avium complex disease patients: clinical symptoms of subjects (cough, sputum and hemosputum etc. ), chest radiographic findings, examination of sputum (smear and culture) and clinical laboratory test results.
3) Study on interaction with clarithromycin and levofloxacin in pulmonary Mycobacterium avium complex disease patients: clinical outcome of subjects (smear and culture test).
2013 | Year | 04 | Month | 24 | Day |
2016 | Year | 04 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012370
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |